openPR Logo
Press release

microRNA Market Research 2021-Competitive Insights: Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA

09-06-2021 02:14 PM CET | Health & Medicine

Press release from: Market Insights Reports

The Global microRNA Market Report Forecast 2021 - 2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). Further, the report also takes into account the impact of the novel COVID-19 pandemic on the microRNA market and offers a clear assessment of the projected market fluctuations during the forecast period. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

The global MicroRNA (miRNA) market size is projected to reach US$ 382.1 million by 2027, from US$ 183.8 million in 2020, at a CAGR of 10.5% during 2021-2027.

Get a Sample PDF Copy of the Report:

https://www.marketinsightsreports.com/reports/07123064177/global-microrna-mirna-market-size-status-and-forecast-2021-2027/inquiry?mode=69

Top Key Players in the Global microRNA Market: Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., BioGenex, SeqMatic LLC

Industry News and Updates:

Research reveals how subtle changes in a microRNA may lead to ALS

This latest research on microRNAs (miRNAs), regulatory molecules that act like brakes to reduce the production of proteins, has implications for studying and treating the underlying causes of amyotrophic lateral sclerosis (ALS) and other neurological and psychiatric disorders. The work could also be applicable to a wide range of diseases involving changes in gene expression levels, like cancer.

MicroRNA-34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel

Aberrant DNA methylation is widely observed in various types of cancer, and expression of microRNAs (miRNAs/miRs) is suppressed by DNA methylation. The present study explored tumor suppressor miRNAs downregulated by DNA methylation in endometrial cancer cells, as the basis of a novel therapeutic approach for endometrial cancer. Among 821 candidate miRNAs, miR-34b was identified as an upregulated miRNA after demethylation treatment in all four endometrial cancer cell lines (HEC-108, SNG-II, Ishikawa and HHUA) examined. miR-34b expression with or without demethylation treatment in cancer cells was confirmed by TaqMan quantitative PCR. MYC and MET, the predicted target genes of miR-34b, were downregulated at both the RNA and protein levels following miR-34b overexpression.

Market Segmentation:

By Type:

Sample collection
miRNA cDNA Synthesis
Profiling & Purification
Detection
Functional Studies

By Application:

Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others

Regional Analysis:

The report offers an in-depth assessment of the growth and other aspects of the microRNA market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Report Methodology:

The information enclosed in this report is based upon both primary and secondary research methodologies.
The Primary research methodology includes the interaction with service providers, suppliers, and industry professionals. The Secondary research methodology includes a meticulous search of pertinent publications like company annual reports, financial reports, and exclusive databases.

Inquiry for Best Discount here:

https://www.marketinsightsreports.com/reports/07123064177/global-microrna-mirna-market-size-status-and-forecast-2021-2027/discount?mode=69

Important Features that are under Offering and Key Highlights of the Reports:

– Detailed overview of microRNA Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc.
– Historical, current and projected market size in terms of volume and value.
– Recent industry trends and developments
– Competitive landscape of microRNA Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics, and their latest trends, along with pertinent market segments and sub-segments.

-Analytical Tools: The global microRNA market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

The research includes historic data from 2016 to 2021 and forecasts until 2027 which makes the reports an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Explore Full Report with Detailed TOC Here:

https://www.marketinsightsreports.com/reports/07123064177/global-microrna-mirna-market-size-status-and-forecast-2021-2027?mode=69

Customization of this Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please contact our sales professional (sales@marketinsightsreports.com ), we will ensure you obtain the report which works for your needs.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:

Market Insights Reports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Market Insights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release microRNA Market Research 2021-Competitive Insights: Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA here

News-ID: 2382676 • Views:

More Releases from Market Insights Reports

RTK Receiver Market Competition Strategies, Revenue Analysis, Key Players, Regio …
The qualitative report published by market intelligence data research on the RTK Receiver Market offers an in-depth examination of the current trends, latest expansions, conditions, market size, various drivers, limitations, and key players along with their profile details. The RTK Receiver market report offers the historical data for 2017 to 2022 and also makes available the forecast data from the year 2023 to 2029 which is based on revenue. With
Head Emergency Immobilizer Market: Size, Share, Trends, Growth, and Revenue Projections by 2029 by Key Players | Boscarol , Abronn , MeBer , Spencer
Head Emergency Immobilizer Market: Size, Share, Trends, Growth, and Revenue Proj …
****Revolutionary New Findings have been Uncovered in the Latest Research Report.….! Global Head Emergency Immobilizer market Size, Status, and forecast for the 2023-2029 .The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the
4D Diagnostic Ultrasound System Market to See Huge Growth & Profitable Business 2023-2029 by Key Players | GE Healthcare , Samsung Healthcare , Philips , Alpinion
4D Diagnostic Ultrasound System Market to See Huge Growth & Profitable Business …
****Revolutionary New Findings have been Uncovered in the Latest Research Report.….! Global 4D Diagnostic Ultrasound System market Size, Status, and forecast for the 2023-2029 .The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of
Caulk Market 2023 Report Provides Pin Point Analysis of Changing Competition Dyn …
The qualitative report published by market intelligence data research on the Caulk Market offers an in-depth examination of the current trends, latest expansions, conditions, market size, various drivers, limitations, and key players along with their profile details. The Caulk market report offers the historical data for 2017 to 2022 and also makes available the forecast data from the year 2023 to 2029 which is based on revenue. With the help

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and